期刊
HAEMATOLOGICA
卷 101, 期 6, 页码 672-679出版社
FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2015.141796
关键词
-
类别
资金
- NCI NIH HHS [K08 CA188529, P30 CA008748] Funding Source: Medline
Wilms tumor 1 (WT1) has long been implicated in acute myeloid leukemia. It has been described to be both over-expressed and mutated in different forms of acute myeloid leukemia, and overexpression has been reported to play a prognostic role in this disease. However, the precise mechanism through which WT1 may play a role in leukemogenesis has remained elusive. In recent years, new evidence has emerged that points towards a novel role of WT1 mutations in the deregulation of epigenetic programs in leukemic cells through its interaction with TET proteins. Herein we review the current status of the field and its therapeutic and prognostic implications in acute myeloid leukemia.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据